NEW DELHI – It is a low-cost Covid-19 vaccine that today holds out hope for low- and middle-income countries that have been elbowed out by richer nations amid a scramble for vaccines.

But attaining this pedestal has not been easy for the team of researchers behind this vaccine in the United States who have had to jump through several hoops to get this far.

Please subscribe or log in to continue reading the full article.

Get unlimited access to all stories at $0.99/month

• Latest headlines and exclusive stories
• In-depth analyses and award-winning multimedia content
• Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months*

*Terms and conditions apply.

Join ST’s Telegram channel here and get the latest breaking news delivered to you.

Source: Read Full Article